title: Cardiac complications and manifestations of chemotherapy for cancer.
authors: Cardiovascular Division, British Heart Foundation Centre of Excellence, The Rayne Institute, King's College London, St Thomas' Hospital, London, UK Department of Cardiology, Guy's & St Thomas' NHS Foundation Trust, London, UK.
authors: Muhammed Zeeshan
authors: MZ
authors: Khawaja
authors: Department of Medical Oncology, Royal Marsden NHS Foundation Trust, London, UK.
authors: Catherine
authors: C
authors: Cafferkey
authors: Department of Cardiology, Guy's & St Thomas' NHS Foundation Trust, London, UK.
authors: Ronak
authors: R
authors: Rajani
authors: Cardiovascular Division, British Heart Foundation Centre of Excellence, The Rayne Institute, King's College London, St Thomas' Hospital, London, UK Department of Cardiology, Guy's & St Thomas' NHS Foundation Trust, London, UK.
authors: Simon
authors: S
authors: Redwood
authors: Department of Medical Oncology, Royal Marsden NHS Foundation Trust, London, UK.
authors: David
authors: D
authors: Cunningham
mesh_terms: D020533:Angiogenesis Inhibitors / Q000009:adverse effects; D018943:Anthracyclines / Q000009:adverse effects; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects*; D006331:Heart Diseases / Q000139:chemically induced* / Q000517:prevention & control; D006333:Heart Failure / Q000139:chemically induced; D006801:Humans; D006973:Hypertension / Q000139:chemically induced; D009369:Neoplasms / Q000188:drug therapy*; D018570:Risk Assessment; D012307:Risk Factors
chemical_list: D020533:Angiogenesis Inhibitors; D018943:Anthracyclines; D061067:Antibodies, Monoclonal, Humanized
keywords: Cardio-Oncology; Cardiomyopathy; Cardiotoxicity; Chemotherapy; Heart Failure